|
864-941-8129
(voice)
864-941-8133 (fax)
hataylor@ggc.org |
Director, Diagnostic Laboratories
(Senior Clinical Laboratory
Geneticist)
- B.S. (1965), MS (1967), Ph.D. (1971), University of Tennessee,
Knoxville
- Postdoctoral Fellow, Department of Pediatrics, Johns Hopkins
University School of Medicine, Baltimore, MD, 1971-1973
|
|
As director of the diagnostic laboratories, Dr. Taylor has
responsibility for the cytogenetic, molecular, metabolic, and
prenatal screening laboratories. Dr. Taylor has primary responsibility
for the biochemical section which includes the metabolic and prenatal
screening labs. His research interests include the inborn errors
of metabolism, in particular, the lysosomal storage disorders
and methods of their diagnosis and analysis.
Dr. Taylor is a Diplomat of the American Board of Medical Genetics
as a clinical biochemical geneticist and is a Founding Fellow
of the American College of Medical Genetics. He is an active member
of the Society of Inherited Metabolic Disorders, the Society for
the Study of Inborn Errors of Metabolism, American Society of
Human Genetics, and the South Carolina Academy of Science.
Selected Publications:
- Phelan MC, Thomas GR, Saul RA, Rogers RC, Taylor HA,
Wenger DA, McDermid HE. Cytogenetic, biochemical, and molecular
analyses of a 22q13 deletion. Am J Med Genet 43:872-6, 1992.
- Taylor HA and Skinner SA. Beta-Galactosidase deficiency.
Proc Greenwood Genet Cntr 12:19-22, 1993.
- Taylor HA and Thomas GA. Pseudodeficiency of alpha-iduronidase.
J Inher Metab Dis 16:1058-9, 1993.
- Kaye EM, Shalish C, Livermore BS, Taylor HA,
Stevenson RE, Breakfield XO. ß-Galactosidase gene mutations in
patients with slowly progressive Gm1 gangliosidosis. J Child
Neurol 12:242-7, 1997.
- Taylor HA, Rogers C, Jones A, Blouin R: Missed
diagnosis of maple syrup urine disease presenting as a psychiatric disorder.
Proc Greenwood Genetic Center 20:48-50, 2001.
- Wood TC, Flannery D, Kottra J, Longshore J,
Taylor HA: Biochemical and molecular analysis of a patient with congenital
disorder of glycosylation type 1a. Glycobiology 11:906A, 2001.
- Hahn KA, Salomons GA, Tackels-Horne D, Wood TC, Taylor HA, Schroer
RJ, Lubs HA, Jakobs C, Olson RL, Holden KR, Stevenson RE, Schwartz CE: X-linked mental retardation with seizures and carrier
manifestations is caused by a mutation in the creatine transporter gene
(SLC6A8) located in Xq28. Am J Hum Genet 70:1349-1356, 2002.
- Wood TC, Olson RL, Hahn KA, Salomons GS, Tackels-Horne
D, Holden KR, Taylor HA, Schroer RJ, Stevenson RE, Schwartz CE: Identification of creatine transporter deficiency in a large X-linked
mental retardation (XLMR) family. Presented at Annual Meeting of Society of
Inherited Metabolic Disorders, 2002.
|
|
